Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Judith Sebolt-Leopold
Compensatory Pathways Induced by MEK Inhibition Are Effective Drug Targets for Combination Therapy Against Castration-Resistant Prostate Cancer
Molecular Cancer Therapeutics
Cancer Research
Oncology
Related publications
Androgen Receptor Inhibitor–induced “BRCAness” and PARP Inhibition Are Synthetically Lethal for Castration-Resistant Prostate Cancer
Science Signaling
Biochemistry
Cell Biology
Molecular Biology
STAT3 and STAT5A Are Potential Therapeutic Targets in Castration-Resistant Prostate Cancer
Oncotarget
Oncology
Ailanthone: A New Potential Drug for Castration-Resistant Prostate Cancer
Chinese Journal of Cancer
Prostate-Specific Membrane Antigen–Directed Therapy for Metastatic Castration-Resistant Prostate Cancer
Cancer Journal
Cancer Research
Oncology
Salvage Therapy for Castration-Refractory Prostate Cancer Resistant to Docetaxel
Japanese Journal of Urology
Urology
Inhibition of Hedgehog and Androgen Receptor Signaling Pathways Produced Synergistic Suppression of Castration-Resistant Prostate Cancer Progression
Molecular Cancer Research
Cancer Research
Oncology
Molecular Biology
Mp52-01 Combination of Indomethacin and Enzalutamide to Treat Castration-Resistant Prostate Cancer
Journal of Urology
Urology
Aggressive Variants of Castration-Resistant Prostate Cancer
Clinical Cancer Research
Cancer Research
Oncology
Androgen-Regulated miR-32 Targets BTG2 and Is Overexpressed in Castration-Resistant Prostate Cancer
Oncogene
Cancer Research
Genetics
Molecular Biology